Table 3.
Hazard Ratio Estimates and 95% Confidence Intervals for Death Using Different Sizes of Subcohorts (N=13,658)
| AIDS at treatment initiation | ||||
|---|---|---|---|---|
| 23 cohorts ≈500 per cohort | 65 cohorts ≈200 per cohort | 134 cohorts ≈100 per cohort | 271 cohorts ≈50 per cohort | |
| Fixed effects | 1.99 (1.74–2.28) | 2.00 (1.75–2.28) | 2.00 (1.75–2.29) | 2.03 (1.78–2.33) |
| Random effectsa | 1.97 (1.72–2.25) | 1.94 (1.70–2.21) | 1.88 (1.65–2.14) | 1.84 (1.62–2.10) |
| Stratified | 2.00 (1.75–2.28) | 2.00 (1.75–2.28) | 1.99 (1.74–2.28) | 2.02 (1.77–2.32) |
Model assumes a Gaussian random effects distribution.
All analyses were adjusted for age, sex, nadir CD4 count, year of initiation, initial ART regimen, and AIDS defining condition at ART initiation.